Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGaming Realms Regulatory News (GMR)

Share Price Information for Gaming Realms (GMR)

Share Price is delayed by 15 minutes
Get Live Data
31.00    0.00 (0.00%)
Bid:
31.00
Ask:
32.40
Spread: 1.40 (4.516%)
Market Cap: £84.71m
GMR Live PriceLast checked at - London Stock Exchange

Intraday Gaming Realms Share Chart

PDX teams with K?rcher

22 Apr 2010 07:00

RNS Number : 5861K
Pursuit Dynamics PLC
22 April 2010
 



22nd April 2010

 

Pursuit Dynamics PLC

("Pursuit" or "the Company" or "PDX")

 

PDX teams with Kärcher for decontamination joint venture

 

PDX today announces an agreement to form a 50/50 joint venture with Kärcher Futuretech GmbH ("Kärcher"), a wholly owned subsidiary of Alfred Kärcher GmbH, the world's leading manufacturer of high-pressure cleaning equipment, to jointly develop, produce and market civilian and military decontamination and disinfection products for a global market.

 

The joint venture combines Kärcher's experience as a world leader in decontamination solutions with PDX's best in class technology to form a new product range focused on quality, mobility, portability and efficiency.

 

Revenues from the joint venture are expected towards the end of calendar 2010, and will build strongly through 2011. The joint venture will address a multi billion dollar global market that is enjoying rapid growth and which is estimated by the US Chamber of Commerce to be worth over US$4 billion in the US alone.

 

Helmut Stelzmüller, Managing Director of Kärcher, said:

 

"We are pleased to be teaming up with PDX, combining its innovative technologies with our strong experience in the sector. As a joint venture, we will be able to deliver a world leading suite of top quality products for both civilian and military markets, delivering superior cost efficiencies for competitive prices".

 

Commenting on the announcement, Roel Pieper, CEO of PDX, said:

 

"Kärcher is the perfect partner for PDX due to its expertise in the field of decontamination and its track record of creating innovative products. This joint venture has the potential to create a major player in the fast growing global civilian and military decontamination solutions market. We believe the unique products marketed by the joint venture can capture a significant share of the market in the short to medium term".

 

- Ends -

 

 

For Further Information, please contact:

 

Pursuit Dynamics PLC

Roel Pieper, Chief Executive Tel: +44 (0)1480 422050

Donald Bell, Chief Financial Officer

 

Financial Dynamics Ben Foster / Marc Cohen Tel: +44 (0) 20 7831 3113

 

Cenkos Securities plc

Ian Soanes / Max Hartley Tel: +44 (0)20 7397 8924

 

Mirabaud Securities LLP

Rory Scott Tel: +44 (0) 20 7878 3360

 

Notes to Editors

About PDX

·; Pursuit Dynamics PLC (AIM: PDX) owns and commercialises the PDX fluid processing reactor whose benefits include significant reductions in energy usage, process acceleration and result enhancement for industries such as Bio ethanol production, Food & Drink, Brewing, Fire Suppression and Decontamination.

 

·; Pursuit Dynamics is headquartered in Huntingdon, UK and has an office in Norwalk, Connecticut, USA.

 

·; Further information is available at the Company's website: www.pursuitdynamics.com or www.pdx.biz 

 

 

About Alfred Kärcher GmbH

 

Kärcher Futuretech GmbH, a wholly owned subsidiary of Alfred Kärcher GmbH, develops and produces equipment and devices for aid organizations and armed forces. The portfolio includes mobile catering facilities, decontamination systems and water treatment plants.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKKDDQABKDOQB
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20263:38 pmRNSTotal Voting Rights and Share Capital
2nd Jun 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares & Treasury Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20262:42 pmRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNS-RInvestor Presentation
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSAnnual Results 2025
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.